• Aucun résultat trouvé

Advanced quantification in oncology PET

N/A
N/A
Protected

Academic year: 2022

Partager "Advanced quantification in oncology PET"

Copied!
24
0
0

Texte intégral

(1)

Advanced quantification in oncology PET

Irène Buvat

IMNC – UMR 8165 CNRS – Paris 11 University Orsay, France

buvat@imnc.in2p3.fr

http://www.guillemet.org/irene

(2)

Two steps

Radiotracer concentration (kBq/

mL)

•  Glucose metabolism

•  Metabolically active tumor volume

•  etc…

Static imaging Dynamic imaging

(3)

•  Tumor segmentation

•  Identification of indices that best characterize the tumor in a specific context

•  Interpretation of tumor changes during therapy

•  Understanding the relationship between macroscopic parameters (from PET images) and microscopic tumor features

Quantification issues in oncology PET

(4)

•  Tumor segmentation

•  Identification of indices that best characterize the tumor in a specific context

•  Interpretation of tumor changes during therapy

•  Understanding the relationship between macroscopic parameters (from PET images) and microscopic tumor features

Quantification issues in oncology PET

(5)

Current quantification in oncology PET

Tracer uptake (kBq/mL)

SUV (Standardized Uptake Value)

=

Tracer uptake

Injected activity / patient weight

SUV ~ metabolic activity of tumor cells

(6)

Comparing 2 PET scans : current approach

•  Need to identify and possibly delineate the tumors

•  Each tumor = 1 single SUV

•  Change compared to an empitical threshold (provided in recommendations such as EORTC, PERCIST)

•  Tedious when there are many tumor sites

~12 weeks

PET1 PET2

SUV=10

SUV=5 SUV=5

SUV=2

(7)

A novel parametric imaging approach

Goal : Get an objective voxel-based comparison of 2 PET/

CT scans

~ 12 weeks

PET1 PET2

(8)

1.  PET image registration based on the CT associated with the PET scans

PET2 PET1

3. Identification of voxels in which SUV significantly changed between the 2 scans using a biparametric analysis

Main steps

2. Voxel-based subtraction of the 2 image volumes

PET2

PET1 PET1-PET2’

- T

21

=

(9)

VOI selection

Step 1

Registration of the PET volumes using the T21 transformation Identification of the transformation needed to realign the 2 CT

T

21

(rigid transform using Block Matching)

CT2 CT2

CT1 CT2

PET1 PET2

PET1 PET2

T

21 realigned with

(10)

Subtraction of the 2 realigned PET scans

Step 2

PET1/CT1

T21{PET2/CT2}

- =

T21{PET2} – PET1/CT1

Each point

corresponds to a voxel

(11)

Identification of the significant tumor changes in the 2D-space by solving a Gaussian mixture model

Step 3

xi PET1(i)-PET2(i) PET1(i)

f(x

i

| θ ) = p Σ

k

φ (x

i

| µ

k

, Σ

k

)

k=1 K

mixture density

mixture parameters 2D Gaussian density θ : vector of parameters (p1, … pK, µ1, ….µK, Σ1, … ΣK)

(12)

Step 3: results

0

-3

ΔSUV

Parametric image ΔV: volume with a significant change

ΔSUV: change magnitude

Nb of voxels

[PET1] SUV

Background

Physiological changes Tumor voxels

(13)

Example

Identification of small tumor changes (lung cancer)

Progressive*

PET3 T21{PET2} - PET1

after solving the GMM

+1.3

PET3 PET1 T21{PET2} T21{PET2} - PET1

after solving the GMM +1.6

PET1 T21{PET2}

(14)

Clinical validation : 28 patients with metastatic colorectal cancer

•  All tumors identified as progressive tumors at D14 were confirmed as such 6 to 8 weeks after based on CT (RECIST criteria)

•  Among the 14 tumors identified as progressive tumors by RECIST criteria, 12 were identified as such at D14 using PI while only 2 were identified using EORTC criteria (SUVmax)

78 tumors with 2 PET/CT (baseline and 14 days after starting treatment)

NPV PPV Sensitivity* Specificity

EORTC 91% 38% 85% 52%

PI 100% 43% 100% 53%

* for detecting lesions

(15)

time (weeks)

0 12 23 35 46

Longitudinal study

Problem : characterize the tumor changes No method, each scan is usually compared

only to the previous one

Comparing more than 2 PET/CT scans

(16)

First step: PET image registration based on the associated CT

A parametric imaging solution

… T

21

T

31

0 12 23 35 46

Use of the transformation identified based on the CT to register the PET scans

Time (weeks)

(17)

Model : a factor analysis model

  SUV units

Decreasing uptake over time

f2(t)

Increasing uptake over time

f3(t)

time t

I1(i). + I2(i). + I3(i).

Stable uptake t over time

f1(t) SUV

voxel i

SUV ( i , t ) = I

k

( i ).

k = 1

K

f

k

( t ) + ε

k

( t ) Σ

t

(18)

Priors :

-  Non-negative I

k

(i) coefficients -  Non-negative f

k

(t) values

-  In each voxel, the variance of the voxel value is roughly proportional to the mean

Solving the model

Iterative identification of I

k

(i) et f

k

(t) (Buvat et al Phys Med Biol 1998) using a Correspondence Analysis followed by an oblique rotation of the orthogonal eigenvectors

SUV ( i , t ) = I

k

( i ).

k = 1

K

f

k

( t ) + ε

k

( t )

Σ

(19)

Sample results

Lung cancer patient with 5 PET/CT scans

0 12 23 35 46 weeks

Normalized SUV

(20)

Why is such an approach useful?

Heterogeneous tumor responses can be easily identified

0 12 23 35 46 weeks

Normalized SUV

(21)

Sample results: early detection of tumor recurrence (1)

12 23 35 46 weeks

T1

T2

2 cyc-4 cyc-3 cyc-no cycle

12 weeks

2 cycles

T1

T2

12 23 35 weeks

2 cyc - 4 cyc - 3 cycles

T1

T2

12 23 weeks

2 cycles - 4 cycles

T1

T2

(22)

12 23 weeks

2 cycles - 4 cycles

B T2

T3

EORTC : no tumor recurrence detected at PET3

SUVmean

0 2 4 6 8 10 12 14

1 2 3 4 5

Examen

SUVmoy T2

SUVmoy T3

lol

PET scan

PI : tumor recurrence detected at PET3

Sample results: early detection of tumor recurrence (2)

(23)

Discussion / conclusion

-  No need to precisely delineate the tumors

-  Makes it possible to detect small changes in metabolic activity

-  Summarizes changes between two or more scans in a single image

-  Shows heterogeneous tumor response within a tumor or

between tumors

(24)

Thanks to

Hatem Necib, PhD

Jacques Antoine Maisonobe, PhD student Michaël Soussan, MD

Camilo Garcia, MD, Institut Jules Bordet, Bruxelles Patrick Flamen, MD, Institut Jules Bordet, Bruxelles Bruno Vanderlinden, MSc, Institut Jules Bordet, Bruxelles

Alain Hendlisz, MD, Insitut Jules Bordet, Bruxelles

Références

Documents relatifs

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a

With regards to daily practice, most of the centers use a reconstruction optimized for diagnostic images in addition to the use of EARL compliant images, half of them using

To segment tumor in PET images using multiple features, the spatial evidential clustering algorithm, e.g., SECM [8], is fully improved by integrating unsupervised distance

For this type of in vitro experiments, where cells are followed individually, the automaton remains the best way to model the system: time is counted as the number of cells that

The proposed framework con- sists of 3 steps: seed detection giving a set of seeds susceptible to belong to the tumor; seed selection allowing to delete aberrant seeds and to

Index Terms— PET/CT, breast cancer, lymph nodes, tumor seg- mentation, region-based features, feature analysis, Random Forest, U-Net,

•  Efforts to go beyond SUV (simplified kinetic analysis, parametric imaging, texture analysis, pattern recognition) should be pursued. * Visser et al J Nucl

Highly realistic PET and SPECT images can be simulated using the Monte Carlo approach, by using ultra-high resolution activity maps as input. (regardless of